Maintenance of myocyte volume homeostasis during stress by diazoxide is cardioprotective

Ashraf S Al-Dadah1, Rochus K Voeller, Richard B Schuessler

  • 1Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Insights

Diazoxide effectively prevents myocyte swelling and preserves contractility during metabolic inhibition, independent of ATP-sensitive potassium channels. This suggests a novel mechanism for protecting heart cells from stunning.

Area of Science:

  • Cardiology
  • Cell Physiology
  • Biochemistry

Background:

  • Myocyte swelling and reduced contractility occur during hyperkalemic cardioplegia and hyposmotic stress.
  • Diazoxide, an adenosine triphosphate-sensitive potassium channel (K(ATP)) opener, previously attenuated these effects.
  • The current study investigates diazoxide's impact on metabolic inhibition-induced myocyte changes and explores underlying mechanisms.

Purpose of the Study:

  • To determine the effect of diazoxide on myocyte swelling and contractility following metabolic inhibition.
  • To elucidate the potential mechanisms by which diazoxide exerts its protective effects.

Main Methods:

  • Isolated rabbit myocytes were subjected to metabolic inhibition (using sodium cyanide and 2-deoxyglucose) with or without diazoxide.
  • Specific adenosine triphosphate-sensitive potassium (K(ATP)) channel blockers (HMR1098 and 5-hydroxydeconoate) were used to investigate the role of sarcolemmal and mitochondrial K(ATP) channels.
  • Myocyte volume and contractility were measured before, during, and after the intervention.

Main Results:

  • Metabolic inhibition led to significant myocyte swelling and decreased contractility.
  • Diazoxide completely prevented myocyte swelling and attenuated the reduction in contractility.
  • The protective effects of diazoxide were observed irrespective of the presence of K(ATP) channel blockers.

Conclusions:

  • Diazoxide attenuates myocyte swelling and preserves contractility during metabolic inhibition, independent of K(ATP) channels.
  • These findings suggest a K(ATP)-independent role for diazoxide in maintaining myocyte volume homeostasis.
  • Preventing myocyte swelling improves contractility, supporting the hypothesis that swelling contributes to myocardial stunning.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...